These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 3794567

  • 21. The role of herd immunity in control of measles.
    Black FL.
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [Abstract] [Full Text] [Related]

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 23. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ, Jain N, Stevenson J, Männikkö N, Molinari NA.
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [Abstract] [Full Text] [Related]

  • 24. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P, Garly ML, Balé C, Martins C, Jensen H, Lisse I, Whittle H.
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Vaccines inf the prevention of fecal hazards].
    Saliou P.
    Bull Soc Pathol Exot; 1998 Sep; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas.
    Pinheiro FP, Corber SJ.
    World Health Stat Q; 1997 Sep; 50(3-4):161-9. PubMed ID: 9477544
    [Abstract] [Full Text] [Related]

  • 33. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
    Samoilovich EO, Kapustik LA, Feldman EV, Yermolovich MA, Svirchevskaya AJ, Zakharenko DF, Fletcher MA, Titov LP.
    Cent Eur J Public Health; 2000 Aug; 8(3):160-3. PubMed ID: 10965439
    [Abstract] [Full Text] [Related]

  • 34. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S.
    Cancer; 2004 Aug 01; 101(3):635-41. PubMed ID: 15274078
    [Abstract] [Full Text] [Related]

  • 35. Pulse immunization -- polio eradication strategy.
    Indian Med Trib; 1994 Sep 30; 2(16):4. PubMed ID: 12179217
    [Abstract] [Full Text] [Related]

  • 36. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
    Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL.
    Bull World Health Organ; 1997 Sep 30; 75(1):69-80. PubMed ID: 9141752
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.